ADPribosylation and Ubiquitination; post-translational interplay
This project aims to investigate the interplay between ubiquitination and ADPribosylation in cellular processes to develop novel therapeutic strategies for diseases like infections and cancer.
Projectdetails
Introduction
Post-translational modification of proteins is essential in regulating proper cellular homeostasis. The attachment and removal of the small protein Ubiquitin (Ub) is, among others, involved in regulating immune response, cell cycle progression, and proteasome-mediated protein degradation.
Role of ADPr
The (de)conjugation of adenosine-di-phosphate ribose (ADPr) on the other hand is essential in regulating DNA damage responses and apoptosis. ADPribosylation and ubiquitination both dictate a highly complex signaling code. Intriguingly, these two PTM systems also communicate, as Ub was recently found to be ADPribosylated on multiple different positions.
Importance of Ubiquitination
This new layer of controlling ubiquitination plays important roles in intracellular bacterial replication, DNA damage repair, and tumor development. Understanding this fascinating post-translational interplay and the role the different UbADPr-isotypes play in cell biology is crucial to develop novel strategies for therapeutic intervention in diseases such as infectious diseases and cancers.
Research Questions
What are the mechanisms, biochemical scope of protein-protein interactions, cell biological consequences, and differences between these non-studied UbADPr linkages?
Proposed Study
I propose to study the entire system of dynamic ADPribosylation of Ub and explain the molecular details of the (de)conjugating enzymes. I will explore the cell biological networks involved and exploit the key enzymes for inhibitor discovery en-route to future therapeutic intervention.
Methodology
- Develop novel chemical methodologies.
- Create a set of new substrates, activity-based probes, and assay reagents.
- Use these tools to profile specificity and preferences of the involved enzymes.
- Study the interactions and pathways in cells.
- Screen for small molecule inhibitors.
Expertise and Goals
Using my expertise in protein synthesis and chemical- and structural biology, I aim to unveil the details of this until now poorly studied, but crucial, hidden layer of post-translational interplay in an unbiased manner.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.999.625 |
Totale projectbegroting | € 1.999.625 |
Tijdlijn
Startdatum | 1-1-2024 |
Einddatum | 31-12-2028 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- ACADEMISCH ZIEKENHUIS LEIDENpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
(Re-)Writing the Ubiquitin Code – Manipulating Polyubiquitin Chain Linkage to Investigate Ubiquitin Signalling in Genome Maintenance and BeyondThis project aims to develop innovative tools for studying polyubiquitylation's role in genome maintenance and its implications for cancer and aging, enhancing our understanding of cellular signaling pathways. | ERC Advanced... | € 2.499.799 | 2025 | Details |
The origin and impact of impaired ubiquitin signaling in the degeneration of neuronsThis project aims to investigate dysregulated ubiquitin signaling as an early cause of neurodegeneration, using innovative human neuronal models to enhance understanding and treatment of Alzheimer's disease. | ERC Advanced... | € 2.500.000 | 2024 | Details |
Development and commercialization of a kit for profiling enzyme activity in liquid biopsiesDeveloping a high-throughput PTM-profiling tool to monitor ubiquitination in clinical samples for discovering diagnostics and therapeutics in autoimmunity. | ERC Proof of... | € 150.000 | 2022 | Details |
Ubiquitin-Proteasome System crosstalk with MetabolismThis project aims to elucidate the regulatory crosstalk between ubiquitination and cellular metabolites using advanced biophysical techniques to enhance understanding of metabolic homeostasis. | ERC Advanced... | € 2.089.688 | 2023 | Details |
Deciphering the regulatory logic of the ubiquitin systemThis project aims to elucidate the substrate recognition mechanisms of E3 ubiquitin ligases using functional genetic approaches to enhance understanding of the ubiquitin-proteasome system for therapeutic applications. | ERC Starting... | € 1.528.843 | 2025 | Details |
(Re-)Writing the Ubiquitin Code – Manipulating Polyubiquitin Chain Linkage to Investigate Ubiquitin Signalling in Genome Maintenance and Beyond
This project aims to develop innovative tools for studying polyubiquitylation's role in genome maintenance and its implications for cancer and aging, enhancing our understanding of cellular signaling pathways.
The origin and impact of impaired ubiquitin signaling in the degeneration of neurons
This project aims to investigate dysregulated ubiquitin signaling as an early cause of neurodegeneration, using innovative human neuronal models to enhance understanding and treatment of Alzheimer's disease.
Development and commercialization of a kit for profiling enzyme activity in liquid biopsies
Developing a high-throughput PTM-profiling tool to monitor ubiquitination in clinical samples for discovering diagnostics and therapeutics in autoimmunity.
Ubiquitin-Proteasome System crosstalk with Metabolism
This project aims to elucidate the regulatory crosstalk between ubiquitination and cellular metabolites using advanced biophysical techniques to enhance understanding of metabolic homeostasis.
Deciphering the regulatory logic of the ubiquitin system
This project aims to elucidate the substrate recognition mechanisms of E3 ubiquitin ligases using functional genetic approaches to enhance understanding of the ubiquitin-proteasome system for therapeutic applications.